The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: A word of caution

Journal of Vascular Surgery

Volumn 36, Issue 3, 2002, Pages 464-468

  Bolton, William D ^a   Cull, David L ^a   Taylor, Spence M ^a   Carsten III, Christopher G ^a   Snyder, Bruce A ^a   Sullivan, Timothy M ^a   Youkey, Jerry R ^a   Langan III, Eugene M ^a   Gray, Bruce H ^a  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ALLOGRAFT; ARM; ARTERY RUPTURE; ARTICLE; BLEEDING; CAUSE OF DEATH; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FEMORAL VEIN; FOLLOW UP; GRAFT INFECTION; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEEDLE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THORAX; THROMBECTOMY; THROMBOSIS; TREATMENT OUTCOME; VASCULAR ACCESS; VEIN GRAFT;

EID: 0036736333     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.126546     Document Type: Article

References (14)

1. Hirth RA, Turenne MN, Woods JD, Young EW, Port FK, Pauly MV, et al. Predictors of type of vascular access in hemodialysis patients. JAMA 1996;276:1303-8.
2. Coburn MC, Carney WI. Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg 1994;20:896-904.
3. Bhandari S, Wilkinson A, Sellars L. Saphenous vein forearm grafts and goretex thigh grafts as alternative forms of vascular access. Clin Nephrol 1995;44:325-8.
4. Taylor SM, Eaves GL, Weatherford DA, McAlhany JC, Russell HE, Langan EM. Results and complications of arteriovenous access dialysis grafts in the lower extremity: a five-year review. Am Surg 1996;62:188-91.
5. Schwab DP, Taylor SM, Cull DL, Langan EM, Snyder BA, Sullivan TM, et al. Isolated arteriovenous dialysis access graft segment infection: the results of segmental bypass and partial graft excision. Ann Vasc Surg 2000;14:63-6.
6. Bhat DJ, Tellis VA, Kohlberg WI, Driscoll B, Veith FJ. Management of sepsis involving expanded polytetrafluoroethylene grafts for hemodialysis access. Surgery 1980;87:445-50.
7. Matsuura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA, Kirby LB. Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 2000;14:50-5.
8. Fujitani RM, Bassiouny HS, Gewertz BL, Glagov S, Zarins CK. Cryopreserved saphenous vein allogenic homografts: an alternative conduit in lower extremity arterial reconstruction in infected fields. J Vasc Surg 1992;15:519-26.
9. Verhelst R, Lacroix V, Vraux H, Lavigne JP, Vandamme H, Limet R. et al. Use ofcryopreserved arterial homografts for management of infected prosthetic grafts: a Multicentric study. Ann Vasc Surg 2000;14:602-607.
10. The Vascular Access Work Group. NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 1997;30(suppl 3):150-91.
11. Lenz BJ, Veldenz HC, Dennis JW, Khansarinia S, Atteberry, LR. A three year follow-up on standard versus thin wall PTFE grafts for hemodialysis. J Vasc Surg 1998;28:464-70.
12. Benedetto B, Lipkowitz G, Madden R. Kurbanov A, Hull D, Miller M, et al. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. J Vasc Surg 2001;34:139-42.
13. Harris L, O'Brien-Irr M, Ricotta JJ. Long-term assessment ofcryopreserved vein bypass grafting success. J Vasc Surg 2001;33:528-32.
14. Berman SS, Glickman MH, Hurwitz RL, Strayhorn EC, Fogle MA, McEnroe CS. Cryopreserved human saphenous vein allografts and their use in construction of chronic hemodialysis access. In: Sommer BG, Henry ML, editors. Vascular access for hemodialysis II. Philadelphia: WL Gore and Associates, and Precept Press; 1991. p. 219-28.